Charley J. Kludas-Mackenzie

792 Elizabeth St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.

Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.

Journal: Journal of virology

Published: September 15, 2025

Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza.

Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza.

Journal: Molecular therapy. Nucleic acids

Published: August 22, 2025

Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment.

Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment.

Journal: Stem cell reports

Published: March 23, 2023

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2.

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: September 29, 2022

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.

Journal: Cell

Published: October 28, 2020

Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model.

Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model.

Journal: Mucosal immunology

Published: November 26, 2018

Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.

Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.

Journal: Virology journal

Published: April 05, 2017

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 20, 2016

Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation.

Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation.

Journal: Immunology and cell biology

Published: November 09, 2015

Removal of myeloid cytokines from the cellular environment enhances T-cell development in vitro.

Removal of myeloid cytokines from the cellular environment enhances T-cell development in vitro.

Journal: International immunology

Published: August 31, 2013

Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.

Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.

Journal: PLoS pathogens

Published: October 08, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026